Sort by

Send to:

Choose Destination

Links from PubMed

Items: 5


A cohort study of tumoral LINE-1 hypomethylation and prognosis in colon cancer.

Ogino S, Nosho K, Kirkner GJ, Kawasaki T, Chan AT, Schernhammer ES, Giovannucci EL, Fuchs CS.

J Natl Cancer Inst. 2008 Dec 3;100(23):1734-8. doi: 10.1093/jnci/djn359. Epub 2008 Nov 25.


Tumour-infiltrating T-cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review.

Nosho K, Baba Y, Tanaka N, Shima K, Hayashi M, Meyerhardt JA, Giovannucci E, Dranoff G, Fuchs CS, Ogino S.

J Pathol. 2010 Dec;222(4):350-66. doi: 10.1002/path.2774. Review.


Prognostic significance of CDKN2A (p16) promoter methylation and loss of expression in 902 colorectal cancers: Cohort study and literature review.

Shima K, Nosho K, Baba Y, Cantor M, Meyerhardt JA, Giovannucci EL, Fuchs CS, Ogino S.

Int J Cancer. 2011 Mar 1;128(5):1080-94. doi: 10.1002/ijc.25432. Review.


Clinical implications of the LINE-1 methylation levels in patients with gastrointestinal cancer.

Baba Y, Murata A, Watanabe M, Baba H.

Surg Today. 2014 Oct;44(10):1807-16. doi: 10.1007/s00595-013-0763-6. Epub 2013 Oct 23. Review.


Global DNA hypomethylation in prostate cancer development and progression: a systematic review.

Zelic R, Fiano V, Grasso C, Zugna D, Pettersson A, Gillio-Tos A, Merletti F, Richiardi L.

Prostate Cancer Prostatic Dis. 2015 Mar;18(1):1-12. doi: 10.1038/pcan.2014.45. Epub 2014 Nov 11. Review.

Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk